Crater
Glenn Crater, Mississauga CA
Patent application number | Description | Published |
---|---|---|
20120309725 | COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST - Novel combinations of a muscarinic acetylcholine receptor antagonist and a beta 2 agonist for inhaled administration via the nose or mouth, and methods of using them are provided. | 12-06-2012 |
Glenn Crater, North Mississauga CA
Patent application number | Description | Published |
---|---|---|
20140113888 | Novel Combination of Therapeutic Agents - The present invention is directed to the combination of a muscarinic receptor antagonist and a corticosteroid, and the use of said combination in treating diseases mediated via the M | 04-24-2014 |
20140116434 | Dry Powder Inhaler Compositions - Dry powder inhalers comprising a muscarinic acetylcholine receptor antagonist and optionally a beta 2 agonist and/or a corticosteroid for use in the treatment of inflammatory or respiratory tract diseases, such as asthma or COPD. | 05-01-2014 |
Kenneth C. Crater, North Grafton, MA US
Patent application number | Description | Published |
---|---|---|
20140277592 | NETWORKED PROGRAMMABLE INDUSTRIAL CONTROLLERS - Different devices or subsystems, including programmable industrial controllers, are connected to a common network. Each connected device has the capability for autonomous or quasi-autonomous action based on a common pool of information accessible on the network. For example, all or a subset of devices connected to the network may periodically broadcast status data over the shared network medium; status data may include the current state of the controller and/or environmental conditions that the controller monitors. | 09-18-2014 |